Editas Medicine

/Editas Medicine

Editas Medicine is a leading genome editing company dedicated to treating patients with genetically-defined diseases by correcting their disease-causing genes.

Symbol

Last Closing Price
$27.29

Shares
1,900,000

Effective Date
December 6, 2017

Underwriters

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange